ArticleEsophagus : official journal of the Japan Esophageal Society2026
The poorly differentiated component in endoscopic biopsy predicts submucosal invasion in superficial Barrett's esophageal adenocarcinoma.
Article in Esophagus : official journal of the Japan Esophageal Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimEndoscopic prediction of depth of invasion in superficial Barrett's esophageal adenocarcinoma (s-BEA) is important for treatment selection. This study aimed to evaluate the endoscopic and histopathological characteristics in s-BEA demonstrating submucosal invasion.
methodsWe retrospectively reviewed 105 tumors from 97 patients, diagnosed endoscopically and pathologically with s-BEA in short-segment Barrett's esophagus (60 lesions in 60 patients) and long-segment Barrett's esophagus (45 lesions in 37 patients); 105 s-BEA lesions were classified into 60 intramucosal and 45 submucosal tumors. We compared the clinicopathological and endoscopic characteristics of these tumors. A multivariate analysis was conducted to predict submucosal invasion based on pretreatment endoscopic and histopathological findings. The presence of the poorly differentiated component (PDC) was then assessed histologically in both pretreatment biopsy specimens (biopsy-PDC) and resected specimens.
resultsCompared to intramucosal tumors, submucosal tumors demonstrated significantly higher frequency of the following features: biopsy-PDC (21/45, 46.7%; versus 1/60, 1.7%; odds ratio = 24.9), complex macroscopic type (33/45, 73.3%; versus 15/60, 25.0%; odds ratio = 6.26), and tumor diameter > 20 mm (31/45, 68.9%; versus 13/60, 21.7%; odds ratio = 7.63). In 20 submucosal tumors with biopsy-PDC, the invasion at the biopsy site showed PDC extended to the submucosa in 95.0% (19/20) and was limited to the mucosa in 5.0% (1/20) cases.
conclusionsWe showed biopsy-PDC, tumor diameter greater than 20 mm, and complex macroscopic type independently predict submucosal invasion in Barrett's esophageal adenocarcinoma. Biopsy-PDC may predict submucosal cancer and submucosal invasion at the biopsy site more reliably, independent of endoscopic findings.
Indexed as
Identifiers
41518457What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.